The Department of Justice has asked a judge to approve the $69 billion merger between CVS Health and Aetna, which was closed by the two companies at the end of 2018, Reuters reported. The deal has been hung up on court approval, though it has been approved by all other regulators and the DOJ.

More employers are actively integrating or considering integrating their medical, pharmacy, dental, vision and/or disability benefits under their health and wellness programs in the next five years thanks to the positive impact on employees, a study from Anthem found. 

In anticipation of the 2020 ending of the individual mandate penalizing Americans who don’t have health insurance, Harvard researchers have drawn from Massachusetts’s state-level reform experience to show a falloff in elective surgery is likely.

The Medical Imaging & Technology Alliance (MITA) has issued a statement in support of the recently passed federal requirement that all mammography providers must include information about breast density in reports sent to patients and their physicians.

Crossover Health, a leading provider of comprehensive health services for self-insured employers, announced today that it has acquired the exclusive rights to the technology platform developed by Sherpaa Health, the pioneer of virtual primary care.

General Electric Company (GE) is selling its biopharma business to Danaher for $21.4 billion, the company announced Feb. 25. With a definitive agreement signed between the two parties, GE’s previous plan to spin off its healthcare sector with its own initial public offering is likely put on hold, GE Chairman and CEO Larry Culp told CNBC.

Drug middlemen gobbled up $123.5 million in hidden costs in Kentucky’s Medicaid program, according to a new report from the Kentucky’s Cabinet for Health and Family Services.

The FDA has published a statement emphasizing that thermography is not cleared as an alternative to mammography for breast cancer screening or diagnosis. This comes on the heels of the agency sending La Mesa, California-based Total Thermal Imaging a warning letter for marketing "an unapproved thermography device as a sole screening device for breast cancer and other diseases.”